lysophosphatid
acid
acid
lpa
natur
occur
bioactiv
phospholipid
normal
physiolog
condit
lpa
present
low
level
plasma
nm
concentr
elev
site
tissu
injuri
inflamm
lpa
produc
phospholipid
biosynthesi
cell
membran
lpa
also
produc
extracellularli
sever
cell
type
includ
activ
platelet
leukocyt
epitheli
cell
neuron
cell
tumor
cell
increas
evid
suggest
lpa
play
role
variou
inflammatori
diseas
lpa
regul
variou
development
physiolog
pathophysiolog
process
includ
cell
motil
invas
prolifer
surviv
product
growth
factor
g
proteincoupl
receptor
gpcr
plateletderiv
lpa
play
import
role
tissu
regener
wound
heal
lpa
also
function
chemoattract
promot
motil
variou
type
human
cancer
cell
recent
studi
suggest
tumor
cell
stimul
product
lpa
activ
platelet
enhanc
tumor
growth
cytokinemedi
bone
destruct
specif
inhibit
lpa
receptor
abolish
migrat
cancer
cell
respons
malign
ascit
contain
lpa
increas
express
lpa
receptor
associ
increas
level
invas
ovarian
cancer
cell
thu
lpa
divers
biolog
activ
implic
tumor
initi
progress
includ
increas
cell
surviv
angiogenesi
invas
metastasi
paradox
lpa
also
induc
apoptosi
certain
cell
neuron
cell
epitheli
cell
differ
tissu
myeloid
progenitor
cell
hippocamp
neuron
cell
howev
mechan
lpa
induc
apoptosi
remain
unclear
death
receptor
also
known
rel
new
member
tumor
necrosi
factor
tnf
receptor
famili
possess
cytoplasm
death
domain
previou
studi
indic
ectop
express
mammalian
cell
induc
apoptosi
recent
studi
suggest
induc
apoptosi
mitochondriadepend
pathway
current
studi
determin
mechan
lpa
induc
apoptosi
surprisingli
found
lpa
induc
apoptosi
via
upregul
express
death
receptor
hela
cell
addit
result
strongli
suggest
pathway
activ
transcript
factor
creb
respons
lpainduc
upregul
express
apoptosi
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
phosphor
antibodi
pkcdelta
mek
creb
cleav
caspas
parp
purchas
cell
signal
technolog
danver
antibodi
purchas
cayman
chemic
ann
arbor
mi
antibodi
lifespan
bioscienc
seattl
wa
lpa
categori
number
watersolubl
lp
avanti
polar
lipid
alabast
al
angiotensin
ii
pma
insulin
thrombin
ro
pkc
inhibitor
inhibitor
bought
sigmaaldrich
st
loui
mo
pertussi
toxin
ptx
biomol
intern
plymouth
meet
pa
wortmannin
inhibitor
lpa
receptor
antagonist
cayman
chemic
boston
erk
creb
sirna
cell
signal
technolog
sirna
bought
santa
cruz
biotechnolog
ca
jnk
inhibitor
purchas
calbiochem
billerica
mtt
assay
kit
cell
viabil
bought
r
system
minneapoli
mn
tunel
assay
kit
purchas
roch
appli
scienc
usa
adenovir
vector
construct
kit
qbiogen
clone
tool
includ
restrict
enzym
dna
ligas
modifi
enzym
bought
new
england
biolab
promega
chemic
purchas
sigmaaldrich
brand
compani
hela
cell
cultur
dmem
dmem
antibiot
pennstrep
cell
starv
hour
lpa
treatment
indic
experi
inhibitor
usual
pretreat
min
follow
lpa
treatment
except
ptx
pretreat
hour
northern
blot
perform
describ
previous
total
rna
extract
use
trizol
reagent
invitrogen
subject
formaldehydeagaros
gel
electrophoresi
rna
transfer
nylon
membran
amersham
bioscienc
uvcrosslink
hybrid
dctplabel
fragment
see
supplement
figur
supplementari
materi
avail
onlin
http
human
cdna
rrna
use
intern
control
intens
hybrid
band
quantifi
use
imag
j
softwar
western
blot
conduct
previous
describ
brief
cell
wash
cold
pb
one
time
immedi
lyse
lysi
buffer
contain
mm
trishcl
ph
urea
sd
mm
naf
mm
proteas
inhibitor
roch
protein
concentr
determin
bca
kit
fisher
scientif
equal
amount
total
protein
load
protein
separ
trisglycin
sdspage
gel
transfer
pvdf
membran
fisher
scientif
follow
probe
differ
antibodi
visual
ecl
reagent
pcr
primer
design
human
regular
pcr
primer
design
amplif
human
messag
rna
revers
transcript
rt
pcr
primer
also
design
quantit
pcr
qpcr
analysi
primer
target
gene
amplif
rel
control
supplement
supplement
tabl
regular
revers
transcript
pcr
perform
biorad
thermocycl
use
follow
program
min
follow
cycl
follow
extens
min
revers
transcript
pcr
cycl
number
control
cycl
pcr
product
subject
agaros
gel
electrophoresi
quantit
pcr
perform
previous
report
brief
qpcr
mixtur
heat
min
subject
cycl
min
use
system
biorad
cycl
threshold
ct
valu
determin
sampl
ct
valu
normal
intern
control
gene
rel
express
mrna
determin
ct
valu
calcul
use
equat
adenoviru
harbor
differ
dominantneg
dn
pkc
isoform
titrat
ad
cell
cultur
moi
multipl
infect
hr
downregul
express
erk
creb
sirna
technolog
perform
follow
protocol
supplier
two
round
sirna
treatment
conduct
better
knockdown
effici
cell
treat
lpa
differ
concentr
time
point
indic
mtt
assay
perform
accord
recommend
supplier
termin
deoxynucleotidyl
transferas
tdt
mediat
dutp
nick
end
label
tunel
assay
cell
treat
lpa
hr
fix
stain
imag
captur
use
olympu
fluoresc
microscopi
equip
digit
camera
experi
repeat
least
three
time
imag
band
western
blot
northern
blot
pcrqpcr
quantifi
use
imag
j
softwar
nih
websit
data
present
mean
sd
statist
analysi
perform
use
prism
softwar
comparison
either
student
ttest
two
group
oneway
anova
group
p
valu
less
consid
signific
differ
test
whether
lpa
induc
apoptosi
hela
cell
treat
variou
concentr
lpa
hr
lpainduc
apoptosi
hela
cell
determin
mtt
tunel
assay
shown
figur
b
reduct
cell
viabil
determin
mtt
assay
increas
number
tunelposit
cell
indic
apoptot
effect
appar
dosedepend
lowest
level
lpa
treatment
proapoptot
effect
lpa
hela
cell
confirm
apoptot
signal
protein
activ
shown
figur
c
lpa
treatment
significantli
increas
activ
parp
cleavag
interestingli
shown
figur
dosedepend
proapoptot
effect
lpa
accompani
gradual
augment
express
recent
identifi
death
receptor
member
tnf
superfamili
treatment
lpa
chang
level
two
member
tnf
superfamili
next
compar
effect
differ
proapoptot
factor
growth
factor
express
hela
cell
treat
variou
stimuli
includ
angiotensin
ii
agii
ngml
insulin
lpa
lp
ngml
unitml
thrombin
ngml
ngml
phorbol
pma
express
mrna
measur
northern
blot
differ
time
point
indic
shown
figur
note
pma
lpa
significantli
upregul
express
hr
known
induc
sever
cancer
cell
line
pma
also
report
upregul
express
tcell
activ
shown
figur
b
mrna
express
hela
cell
treat
lpa
increas
transient
peak
level
hr
shown
figur
c
lpa
upregul
mrna
express
dosedepend
manner
reach
plateau
result
confirm
rtpcr
supplement
figur
next
sought
determin
whether
lpa
regul
protein
express
follow
similar
time
cours
shown
figur
lpa
treatment
transient
increas
protein
express
hela
cell
earli
hr
peak
level
hr
data
reveal
lpa
receptor
express
hela
cell
figur
b
determin
role
lpar
lpastimul
upregul
treat
cell
antagonist
prior
addit
lpa
shown
figur
c
pretreat
cell
strongli
inhibit
lpainduc
express
suggest
lpainduc
upregul
mediat
lpa
receptor
shown
figur
treatment
lpa
significantli
induc
mek
erk
phosphoryl
determin
mechan
underli
lpainduc
express
first
examin
effect
pertussi
toxin
ptx
inactiv
lpa
receptorcoupl
gio
type
g
protein
shown
figur
treatment
ptx
inhibit
lpainduc
phosphoryl
mek
erk
lpainduc
phosphoryl
mek
erk
also
inhibit
wortmannin
inhibitor
ro
pkc
inhibitor
mek
inhibitor
figur
next
examin
role
kinas
lpainduc
express
shown
figur
b
lpainduc
increas
level
mrna
strongli
inhibit
ro
cellperm
inhibitor
pkc
isoform
anoth
pkc
inhibitor
gf
also
significantli
inhibit
lpainduc
mrna
express
strongli
ro
addit
pkc
inhibitor
mek
inhibitor
inhibitor
wortmannin
also
significantli
inhibit
lpainduc
mrna
express
g
protein
inhibitor
ptx
inhibit
lpainduc
mrna
express
lesser
extent
hand
inhibit
jnk
activ
jnk
inhibitor
effect
lpainduc
increas
mrna
express
togeth
result
suggest
pathway
mediat
lpainduc
express
data
present
figur
strongli
suggest
activ
pkc
function
involv
lpainduc
express
determin
specif
isoform
pkc
contribut
lpainduc
express
first
determin
lpainduc
activ
major
pkc
isoform
hela
cell
treat
lpa
differ
time
indic
activ
pkc
isoform
detect
western
blot
analysi
shown
figur
upon
treatment
lpa
pkc
examin
activ
variou
extent
among
high
level
basal
phosphoryl
significantli
affect
lpa
treatment
similarli
phosphoryl
level
also
slightli
increas
lpa
treatment
time
cours
hand
remark
activ
upon
treatment
lpa
determin
rapid
robust
increas
phosphoryl
level
next
determin
effect
express
dominantneg
form
pkc
isoform
lpainduc
express
shown
figur
b
express
dominantneg
form
effect
lpainduc
express
howev
express
dominantneg
form
almost
complet
block
lpainduc
mrna
express
togeth
data
strongli
suggest
major
pkc
isoform
function
involv
signal
pathway
mediat
lpainduc
express
data
demonstr
first
time
pkc
isoformspecif
transcript
regul
lpainduc
express
data
present
figur
show
lpa
induc
activ
erk
previou
studi
report
lpa
induc
activ
erk
serinethreonin
kinas
known
directli
phosphoryl
transcript
factor
creb
camp
respons
elementbind
protein
thu
thought
determin
whether
lpainduc
activ
pathway
lead
activ
creb
whether
creb
involv
lpainduc
express
shown
figur
lpa
induc
activ
mek
earli
time
point
moreov
lpa
also
strongli
induc
activ
transcript
factor
creb
timedepend
manner
determin
role
molecul
lparegul
express
employ
sirna
approach
shown
figur
b
knockdown
erk
creb
strongli
block
lpainduc
mrna
express
shown
figur
c
western
blot
analysi
confirm
effici
knockdown
express
erk
creb
expect
protein
level
dramat
reduc
erk
crebknockdown
cell
observ
suggest
lpa
induc
express
activ
signal
pathway
subsequ
activ
creb
next
substanti
role
lpainduc
apoptosi
first
determin
apoptot
activ
hela
cell
infect
adenovirus
express
constitut
activ
shown
figur
infect
adenoviru
result
dosedepend
apoptosi
determin
cleavag
parp
indic
apoptosi
activ
control
apoptot
sign
detect
cell
infect
viru
express
lacz
protein
taken
togeth
result
clearli
indic
overexpress
induc
apoptosi
hela
cell
next
determin
whether
lpaupregul
express
account
apoptosi
induc
lpa
determin
effect
knockdown
lpainduc
apoptosi
shown
figur
b
expect
treatment
sirna
strongli
inhibit
express
determin
reduct
protein
level
interestingli
treatment
also
strongli
inhibit
lpainduc
apoptosi
determin
reduct
caspas
activ
parp
cleavag
result
strongli
suggest
lpainduc
apoptosi
mediat
induct
express
lpa
simpl
bioactiv
phospholipid
present
biolog
fluid
plasma
cerebrospin
fluid
csf
lpa
concentr
blood
rang
plasma
serum
studi
experi
carri
use
lpa
rang
patholog
concentr
found
atherosclerot
lesion
vivo
acut
myocardi
infarct
concentr
rang
use
determin
apoptot
activ
lpa
cell
type
epitheli
cell
neuron
cell
lpa
g
proteincoupl
receptor
regul
divers
cellular
process
includ
cell
surviv
apoptosi
mani
differ
cell
type
function
lpa
cell
surviv
factor
well
studi
howev
mechan
lpa
induc
apoptosi
remain
elus
current
studi
use
pharmaceut
inhibitor
dominantneg
mutat
sirna
approach
explor
mechan
underli
lpainduc
apoptosi
end
result
reveal
sever
interest
find
first
lpa
induc
apoptosi
patholog
concentr
hela
cell
second
treatment
lpa
result
remark
upregul
express
third
knockdown
strongli
block
lpainduc
apoptosi
fourth
lpa
receptor
antagonist
inhibit
lpainduc
express
final
inhibit
variou
kinas
regul
transcript
factor
creb
strongli
inhibit
lpainduc
express
togeth
result
strongli
suggest
lpainduc
apoptosi
mediat
upregul
express
via
activ
pathway
lead
activ
transcript
factor
creb
control
express
studi
first
novel
find
identif
effector
mediat
lpainduc
apoptosi
rel
less
character
member
tnf
death
receptor
famili
protein
date
still
remain
orphan
receptor
specif
cognat
ligand
yet
identifi
current
knowledg
cellular
physiolog
role
biolog
function
come
studi
effect
gene
ablat
mice
ectop
express
cultur
cell
recent
studi
report
express
upregul
neurodegen
diseas
alzheim
diseas
ad
amyotroph
later
sclerosi
al
upregul
express
may
contribut
pathogenesi
neurodegen
disord
interestingli
lpa
also
implic
apoptot
neurodegener
howev
mechan
lpa
induc
apoptot
cell
death
remain
elus
studi
data
demonstr
first
time
lpa
upregul
express
knockdown
strongli
block
lpainduc
apoptosi
strongli
suggest
lpa
induc
apoptosi
via
upregul
express
thu
find
lpainduc
apoptosi
mediat
upregul
express
suggest
possibl
lpa
may
contribut
neurodegener
elev
protein
level
second
interest
discoveri
studi
find
lpainduc
express
mediat
activ
transcript
factor
creb
studi
report
exogen
express
could
mimic
ligand
activ
trigger
ligandindepend
downstream
apoptot
signal
cascad
howev
although
overexpress
caus
apoptot
cell
death
found
express
level
elev
sever
tumor
human
elev
express
regul
activ
nfkb
furthermor
author
also
demonstr
express
express
could
induc
tumor
necrosi
treatment
express
also
mediat
activ
nfkb
contrast
find
recent
report
activ
nfkb
inhibit
e
phydroxyphenyl
express
colon
cancer
cell
controversi
observ
might
result
use
differ
experiment
system
differ
cell
line
differ
stimuli
studi
interestingli
current
studi
data
demonstr
lpainduc
express
mediat
activ
creb
find
support
assumpt
differ
stimuli
activ
differ
pathway
lead
activ
differ
transcript
factor
govern
express
lpa
well
known
surviv
factor
howev
also
report
lpa
promot
apoptosi
cell
type
includ
epitheli
cell
differenti
neuron
model
cell
hippocamp
neuron
regard
seemingli
contradictori
effect
lpa
promot
cell
surviv
apoptosi
one
possibl
concentr
lpa
use
induc
apoptosi
higher
use
cell
surviv
exampl
concentr
lpa
promot
cell
surviv
rang
hand
concentr
lpa
use
induc
apoptosi
mostli
higher
possibl
differ
cell
type
express
differ
isoform
lpa
receptor
uniqu
gene
express
regul
pattern
variabl
alter
lpa
signal
review
previous
summari
identifi
signal
pathway
implic
lpainduc
apoptosi
pathway
mediat
lpa
receptor
downstream
signal
cascad
interest
novel
find
current
studi
identif
key
factor
mediat
lpainduc
apoptosi
mechan
lpa
function
surviv
factor
extens
studi
howev
mechan
lpa
regul
cell
apoptosi
remain
larg
unknown
thu
find
lpa
stimul
express
lead
apoptot
cell
death
would
contribut
better
understand
mechan
lpa
regul
apoptosi
identif
new
therapeut
target
